Pakistan approves Russia’s Sputnik V COVID-19 vaccine for emergency use

On Tuesday, Pakistan’s Health Minister Dr Faisal Sultan said, “Russia’s Sputnik-V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China’s Sinopharm and the one developed by AstraZeneca and Oxford University”.

“Sputnik has received EUA (emergency use authorisation),” the Minister, Faisal Sultan, told Reuters in a WhatsApp text message.


The government has given a go-ahead to a local pharmaceutical company for the import and distribution of the Russian-developed Sputnik V, the Dawn newspaper quoted an official as saying.

Another candidate, developed by CanSino Biologics Inc (CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people.

On January 17, Drug Regulatory Authority of Pakistan (DRAP) authorised the Oxford University-AstraZeneca COVID-19 vaccine for emergency use in Pakistan. Then after a couple of days, the regulatory body approved Chinese state-owned firm Sinopharm’s COVID-19 vaccine for emergency use, the second shot to be given approval for the use in the country.

Earlier, Hungary became the first European Union country to approve the Sputnik-V COVID-19 vaccine for public distribution. A short time later the UAE also announced the same decision making it 12th country outside of Russia which has authorised its use.